These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 21086628

  • 1. [Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor].
    Delektorskaia VV, Smirnova EA, Ponomareva MV, Pavlova TV, Pavlov IA.
    Arkh Patol; 2010; 72(4):3-6. PubMed ID: 21086628
    [Abstract] [Full Text] [Related]

  • 2. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H, Ohgi S, Terada T.
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [Abstract] [Full Text] [Related]

  • 3. [Study on expression of matrix metalloproteinases and their inhibitors in parotid gland tumors].
    Xu Y, Chen M.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 18(9):542-4. PubMed ID: 15696952
    [Abstract] [Full Text] [Related]

  • 4. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
    Suzuki M, Iizasa T, Fujisawa T, Baba M, Yamaguchi Y, Kimura H, Suzuki H.
    Invasion Metastasis; 2004 Sep; 18(3):134-41. PubMed ID: 10474026
    [Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.
    Marečko I, Cvejić D, Tatić S, Dragutinović V, Paunović I, Savin S.
    Cancer Biomark; 2004 Sep; 11(1):49-58. PubMed ID: 22820140
    [Abstract] [Full Text] [Related]

  • 6. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 7. [Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis].
    Kondakova IV, Klisho EV, savenkova OV, Kakurina GV, Choĭnzonov EL, Shishkin DA, Mukhamedov MP.
    Biomed Khim; 2008 Oct; 54(5):555-60. PubMed ID: 19105397
    [Abstract] [Full Text] [Related]

  • 8. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY, Yao JF, Chen XD.
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [Abstract] [Full Text] [Related]

  • 9. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
    Bodnar M, Szylberg Ł, Kazmierczak W, Marszalek A.
    J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
    [Abstract] [Full Text] [Related]

  • 10. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [Abstract] [Full Text] [Related]

  • 11. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
    Yang HK, Jeong KC, Kim YK, Jung ST.
    Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E.
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [Abstract] [Full Text] [Related]

  • 13. [Interstitial collagenase, gelatinases A and B and their endogenous inhibitors in squamous cell cervical carcinomas].
    Ryzhakova OS, Zavalishina LÉ, Andreeva IuIu, Solov'eva NI.
    Biomed Khim; 2013 Dec; 59(1):55-64. PubMed ID: 23650722
    [Abstract] [Full Text] [Related]

  • 14. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T, Jiang CX, Li Y, Liu X.
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [Abstract] [Full Text] [Related]

  • 15. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M, Holubec L, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R.
    Anticancer Res; 2005 Dec; 25(5):3387-91. PubMed ID: 16101153
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
    Dong Z, Nemeth JA, Cher ML, Palmer KC, Bright RC, Fridman R.
    Int J Cancer; 2001 Aug 15; 93(4):507-15. PubMed ID: 11477554
    [Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
    Nagel H, Laskawi R, Wahlers A, Hemmerlein B.
    Histopathology; 2004 Mar 15; 44(3):222-31. PubMed ID: 14987225
    [Abstract] [Full Text] [Related]

  • 18. Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer.
    Bumber B, Marjanovic Kavanagh M, Jakovcevic A, Sincic N, Prstacic R, Prgomet D.
    Clin Otolaryngol; 2020 Jan 15; 45(1):55-62. PubMed ID: 31646745
    [Abstract] [Full Text] [Related]

  • 19. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
    Kawata N, Nagane Y, Hirakata H, Ichinose T, Okada Y, Yamaguchi K, Takahashi S.
    Urology; 2007 Jun 15; 69(6):1049-53. PubMed ID: 17572184
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 15; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.